MECHANISMS OF TRANSPORT OF QUINAPRIL IN CACO-2 CELL MONOLAYERS - COMPARISON WITH CEPHALEXIN

Citation
M. Hu et al., MECHANISMS OF TRANSPORT OF QUINAPRIL IN CACO-2 CELL MONOLAYERS - COMPARISON WITH CEPHALEXIN, Pharmaceutical research, 12(8), 1995, pp. 1120-1125
Citations number
20
Categorie Soggetti
Pharmacology & Pharmacy",Chemistry
Journal title
ISSN journal
07248741
Volume
12
Issue
8
Year of publication
1995
Pages
1120 - 1125
Database
ISI
SICI code
0724-8741(1995)12:8<1120:MOTOQI>2.0.ZU;2-K
Abstract
Purpose. To determine the transport mechanisms of quinapril and cephal exin in Caco-2 cell monolayers, a cell culture model of the human smal l intestinal epithelium. Methods. Uptake, transepithelial transport an d intracellular accumulations of these two drugs were measured using C aco-5 cell monolayers grown onto Millicells(TM) and magnetically stirr ed diffusion chambers. Results. Transepithelial transport, apical (AP) (4) uptake and intracellular accumulation of both drugs depended on th e maintenance of a transepithelial proton gradient and temperature of the medium. However, quinapril transport and accumulation, which did n ot display a maximum at approximately pH 6, was more sensitive to prot on gradient change, whereas cephalexin transport was more sensitive to concentration change (range 0.5-5 mM). In addition, quinapril (1 mM) transport was decreased significantly (p<0.05) by 10 mM cephalexin, Io racarbef, Gly-Pro and Phe-Pro, but not by enalapril; whereas cephalexi n (0.1 mM) transport was decreased significantly (p<0.05) by all four compounds. Similarly, AP quinapril (1 mM) uptake was also decreased by 10 mM Ioracarbef, Gly-Pro, cephalexin, and enalapril, but these inhib itory effects (20-50%) were quantitatively less than their inhibitory effects on cephalexin uptake (50-90%). Finally, the AP uptake of quina pril was also significantly (p<0.05) inhibited by FCCP (10 mu g/ml), a miloride (0.5 mM), DEP (0.5 mM), and staurosporine (5 nM). Conclusions . The transport of quinapril in the Caco-2 cells is via a combination of the carrier-mediated proton gradient-dependent peptide transporter and passive diffusion.